SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950123-04-011616
Filing Date
2004-09-30
Accepted
2004-09-30 17:26:18
Documents
16

Document Format Files

Seq Description Document Type Size
1 NASTECH PHARMACEUTICAL COMPANY INC. y03046sv3.htm S-3 209177
2 EX-3.1 CERTIFICATE OF INCORPORATION y03046exv3w1.txt EX-3.1 3558
3 EX-3.2 CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION y03046exv3w2.txt EX-3.2 5998
4 EX-3.3 CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION y03046exv3w3.txt EX-3.3 4648
5 EX-3.4 CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION y03046exv3w4.txt EX-3.4 2508
6 EX-3.5 CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION y03046exv3w5.txt EX-3.5 4705
7 EX-3.7 CERTIFICATE OF CORRECTION TO CERTIFICATE OF AMENDMENT TO CERTIFICATE OF I y03046exv3w7.txt EX-3.7 3527
8 EX-3.8 CERTIFICATE OF CORRECTION TO CERTIFICATE OF AMENDMENT TO CERTIFICATE OF I y03046exv3w8.txt EX-3.8 3673
9 EX-3.9 CERTIFICATE OF CORRECTION TO CERTIFICATE OF AMENDMENT TO CERTIFICATE OF I y03046exv3w9.txt EX-3.9 7318
10 EX-3.10 AMENDED AND RESTATED BYLAWS y03046exv3w10.txt EX-3.10 50577
11 EX-4.1 FORM OF COMMON STOCK CERTIFICATE y03046exv4w1.txt EX-4.1 4034
12 EX-4.3 FORM OF INDENTURE y03046exv4w3.txt EX-4.3 123853
13 EX-5.1 OPINION OF PRYOR CASHMAN SHERMAN & FLYNN LLP y03046exv5w1.txt EX-5.1 9572
14 EX-12.1 CALCULATION OF RATIO OF EARNINGS TO FIXED CHARGES y03046exv12w1.txt EX-12.1 2921
15 EX-23.1 CONSENT OF KPMG LLP y03046exv23w1.txt EX-23.1 737
16 EX-25.1 FORM T-1 y03046exv25w1.txt EX-25.1 82522
  Complete submission text file 0000950123-04-011616.txt   523208
Mailing Address 3450 MONTE VILLA PARKWAY BOTHELL WA 98021
Business Address 3450 MONTE VILLA PARKWAY BOTHELL WA 98021 4259083600
NASTECH PHARMACEUTICAL CO INC (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-119429 | Film No.: 041056098
SIC: 2834 Pharmaceutical Preparations